Samco Mutual FundEquity Schemes - Large Cap Fund1.6 years
The scheme seeks to generate long-term capital appreciation from a diversified portfolio predominantly consisting of equity and equity related instruments of large cap companies.
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · Risk-adjusted return (Sharpe) is negative over the available daily history.
Prefer peers if · Prefer WhiteOak Capital Large Cap Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Fail
1.6 years - thin for judging consistency.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Watch
2.15% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -16.5%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
Watch
Vishal Shinde · 0.3 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Watch
Top 10 holdings ≈ 126.5% of the portfolio.
Same-category peers are preloaded into compare when available.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 17%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
Path not in current snapshots
n/a
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
Path not in current snapshots
n/a
1 Jul 2025 – open
Trough 8 Oct 2026 · not recovered
-16.5%
23 Apr 2025 – 25 Jun 2025
Trough 13 May 2025 · recovered in 43 days
-3.5%
31 Mar 2025 – 21 Apr 2025
Trough 7 Apr 2025 · recovered in 14 days
-1.3%
21 Apr 2025 – 23 Apr 2025
Trough 22 Apr 2025 · recovered in 1 days
-0.2%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
3
Vs category
40
Consistency
0
Risk-adjusted
0
Drawdown
59
Mean
20
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
Supporting reads
No supporting reads in the current evidence set.
30 Sept 2026 · 23 holdings · top 10 are 126.5%.
Net Receivables
Unspecified
73.7%
National Stock Exchange Of India Ltd Equity
Financial
9.2%
Others CBLO
Unspecified
7.3%
Samvardhana Motherson International Ltd
Consumer Discretionary
6.1%
Divi's Laboratories Ltd
Healthcare
5.7%
DECISION
Status moved from MONITOR to REVIEW.
22 Sept 2026
DECISION
Status moved from MONITOR to REVIEW.
15 Sept 2026
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
WhiteOak Capital Mutual Fund
Caveat: Higher volatility
Axis Mutual Fund
Caveat: Higher volatility · Deeper drawdown
Canara Robeco Mutual Fund
Caveat: Higher volatility · Deeper drawdown
Groww Mutual Fund
Caveat: Higher volatility · Deeper drawdown
HSBC Mutual Fund
Caveat: Higher volatility · Deeper drawdown
Samco Mutual FundEquity Schemes - Large Cap Fund1.6 years
The scheme seeks to generate long-term capital appreciation from a diversified portfolio predominantly consisting of equity and equity related instruments of large cap companies.
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · Risk-adjusted return (Sharpe) is negative over the available daily history.
Prefer peers if · Prefer WhiteOak Capital Large Cap Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Fail
1.6 years - thin for judging consistency.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Watch
2.15% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -16.5%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
Watch
Vishal Shinde · 0.3 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Watch
Top 10 holdings ≈ 126.5% of the portfolio.
Same-category peers are preloaded into compare when available.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 17%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
29 Oct 2026 · -8.7% over 1Y
8.91
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
29 Oct 2026
-13.0%
1 Jul 2025 – open
Trough 8 Oct 2026 · not recovered
-16.5%
23 Apr 2025 – 25 Jun 2025
Trough 13 May 2025 · recovered in 43 days
-3.5%
31 Mar 2025 – 21 Apr 2025
Trough 7 Apr 2025 · recovered in 14 days
-1.3%
21 Apr 2025 – 23 Apr 2025
Trough 22 Apr 2025 · recovered in 1 days
-0.2%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
3
Vs category
40
Consistency
0
Risk-adjusted
0
Drawdown
59
Mean
20
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
Supporting reads
No supporting reads in the current evidence set.
30 Sept 2026 · 23 holdings · top 10 are 126.5%.
Net Receivables
Unspecified
73.7%
National Stock Exchange Of India Ltd Equity
Financial
9.2%
Others CBLO
Unspecified
7.3%
Samvardhana Motherson International Ltd
Consumer Discretionary
6.1%
Divi's Laboratories Ltd
Healthcare
5.7%
DECISION
Status moved from MONITOR to REVIEW.
22 Sept 2026
DECISION
Status moved from MONITOR to REVIEW.
15 Sept 2026